1. Academic Validation
  2. New 1,2,3-triazoles and their oxime derivatives: AChE/BChE enzyme inhibitory and DNA binding properties

New 1,2,3-triazoles and their oxime derivatives: AChE/BChE enzyme inhibitory and DNA binding properties

  • J Biomol Struct Dyn. 2023 Dec 12:1-18. doi: 10.1080/07391102.2023.2292298.
Ozge Gungor 1 Yunus Emre Veziroglu 1 Aysegul Kose 2 Seyit Ali Gungor 1 Muhammet Kose 1
Affiliations

Affiliations

  • 1 Chemistry Department, Kahramanmaras Sutcu Imam University, Kahramanmaras, Türkiye.
  • 2 Department of Property Protection and Safety, Elbistan Vocational School, Istiklal University, Kahramanmaras, Türkiye.
Abstract

1,2,3-Triazole compounds (1a-3a) and their oxime derivatives (1b-3b) were synthesized. The structures of these synthesized compounds were characterized using common spectroscopic methods. Crystal structures of the compounds 3, 2b and 3b were determined by single crystal X-ray diffraction studies. The acetylcholinesteras (AChE) and butyrylcholinesterase (BChE) cholinesterase inhibitor (ChEI) and DNA/calf serum albumin (BSA) binding properties of the compounds were examined. DNA binding studies have shown that compounds interact with DNA through 1,2,3-triazole and oxime groups. When the binding constant Kb values were compared, it was revealed that compound 3b (Kb = 4.6 × 105 M-1) with oxime in its structure binds more strongly than the Others. In addition, in vitro BSA binding studies showed that compounds 1b and 3b exhibited higher binding affinity. These results confirm that the quenching is due to the formation of a compound resulting from the static quenching mechanism, rather than being initiated by a dynamic mechanism. Likewise, when the Enzyme activity of the compounds was examined, the compounds exhibited high inhibitory activity against AChE. The highest activity was observed for compounds 2b and 3b (8.6 ± 0.05 and 4.8 ± 0.052 µM). It was observed that the compounds were not selective with respect to BChE. Communicated by Ramaswamy H. Sarma.

Keywords

1,2,3-Triazole oxime; AChE/BChE inhibition activity; BSA; DNA.

Figures
Products